Coblopasvir
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 15, 2017 (NCT03416491)
Timeline
Indications
Studied for
Mechanism of action
- Genome polyproteinINHIBITOR
Genome polyprotein inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)c4c3OCO4)cc2)[nH]1)C(C)C- Mol. weight
- 782.9 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068007 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03995485 | Phase 3 | Jun 7, 2017 | Beijing Kawin Technology Share-Holding Co., Ltd., Jilin University, Peking University |
| NCT03416491 | Phase 2 | Feb 15, 2017 | Beijing Kawin Technology Share-Holding Co., Ltd., Peking University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Kawin Technology Share-Holding Co., Ltd. | For profit | 2 | 2 | 2 | 2017 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2017 |
| Jilin University | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1